FDA

RSS

The U.S. Food and Drug Administration (FDA) has issued a final rule to amend its regulations on how and when FDA may determine that a food contact notification (FCN) is no longer effective.

Partly in response to a citizen petition from the American Bakers Association, the U.S. Food and Drug Administration (FDA) is revoking the standards of identity and quality for frozen cherry pie, effective April 15, 2024.

The U.S. Food and Drug Administration (FDA) is requesting $7.2 billion as part of the President’s fiscal year 2025 proposed budget.

After hundreds of children across the U.S. contracted lead poisoning after eating fruit puree pouches containing contaminated cinnamon, the U.S. Food and Drug Administration (FDA) has identified six additional ground cinnamon products that were found to contain elevated levels of lead. The agency has issued a recall.

The U.S. Food and Drug Administration (FDA) has updated its list of chemicals that are undergoing postmarket safety assessment. The list also newly includes information about the status of the postmarket assessments and links to public information about postmarket actions that have been taken.

bioMérieux has entered an agreement with the U.S. Food and Drug Administration (FDA) to collaboratively develop tools to combat foodborne pathogens.

FDA has announced that, thanks to voluntary phase-out by industry, toxic PFAS are no longer being sold by manufacturers for use in food-contact grease-proofing agents in the U.S. FDA also said it is working towards a validated analytical method that would enable the agency to monitor the market for PFAS in food packaging.

In this episode of Food Safety Matters, we are joined by Brian Ronholm, Director of Food Policy for Consumer Reports, who lends his insight as a consumer advocate and former regulator to a discussion around food regulatory policy and food safety legislation. We dissect a variety of current events in food safety, such as toxic heavy metals in baby foods and food additives legislation, from multiple perspectives, including industry, consumer, regulatory, and consumer advocate.

The U.S. Food and Drug Administration (FDA) has issued a guidance for industry that describes how firms can voluntarily engage with FDA before marketing food from genome-edited plants.

As part of the agency’s Leafy Greens STEC Action Plan, the U.S. Food and Drug Administration (FDA) has published a report detailing the results of targeted inspections and microbiological testing of leafy greens grown in Salinas Valley, California during the region’s 2022 harvest season.